ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event

Rhea-AI Summary

ProPhase Labs (NASDAQ: PRPH), a next-generation biotech, genomics, and diagnostics company, has announced its participation in the Virtual Investor Summit Microcap Event on August 20th, 2024. The company will deliver a presentation at 1:00 P.M. ET and be available for one-on-one meetings throughout the day.

The event, themed around 50 micro-cap companies with catalysts and/or strong market performance, offers investors an opportunity to engage with ProPhase Labs directly. The presentation will be accessible via webcast, allowing remote participation. This summit provides a platform for in-depth discussions with top investors in the microcap space and includes a live Q&A session.

GARDEN CITY, NY, Aug. 19, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today announced that it will be presenting at the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

Event: Q3 Investor Summit
Date: August 20^th, 2024
Presentation Time: 1:00 P.M. ET
Location: https://www.webcaster4.com/Webcast/Page/3062/51116

• The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market.
• Take a deep dive with the best Investors in MicroCap
• Live Q & A
• Complimentary to Qualified Investors. Please REGISTER HERE.
  

About ProPhase Labs

ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our multi-billion-dollar potential.

For more information, visit www.ProPhaseLabs.com.

Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
267-880-1111
investorrelations@prophaselabs.com

Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman
514-939-3989
Jboidman@renmarkfinancial.com

FAQ

When is ProPhase Labs (PRPH) presenting at the Virtual Investor Summit Microcap Event?

ProPhase Labs (PRPH) is presenting at the Virtual Investor Summit Microcap Event on August 20th, 2024, at 1:00 P.M. ET.

What type of meetings will ProPhase Labs (PRPH) be available for during the Virtual Investor Summit?

ProPhase Labs (PRPH) will be available for one-on-one meetings throughout the day of the Virtual Investor Summit on August 20th, 2024.

How can investors access ProPhase Labs' (PRPH) presentation at the Virtual Investor Summit?

Investors can access ProPhase Labs' (PRPH) presentation via webcast at https://www.webcaster4.com/Webcast/Page/3062/51116.

What is the theme of the Virtual Investor Summit Microcap Event featuring ProPhase Labs (PRPH)?

The theme of the Virtual Investor Summit Microcap Event is 50 micro-cap companies with a catalyst and/or strong performance in the current market.